COMMUNIQUÉS West-GlobeNewswire

Aleafia Posts Record Revenue in Q3 2018, 36% Increase Over Previous Quarter
26/11/2018
First Quarter of Profitability for Clinic and Cannabis Product Divisions 99% of 98,000 kg Annual Cannabis Production Capacity to Come Online in 2019 TORONTO, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: [...]
GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for EPIDIOLEX® (cannabidiol) oral solution CV in Patients with Dravet Syndrome
26/11/2018
- Primary endpoint achieved with both EPIDIOLEX doses compared to placebo - - Today’s data represents the fourth positive Phase 3 pivotal trial for EPIDIOLEX in Dravet syndrome and Lennox-Gastaut Syndrome - - EPIDIOLEX [...]
Aravive Announces Participation at Upcoming Investor Conference
26/11/2018
HOUSTON, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company, today announced that company management will participate at the following upcoming investor conference [...]
Edge Therapeutics Enters into Merger Agreement with PDS Biotechnology to Form Clinical-Stage Cancer Immunotherapy Company
26/11/2018
-Merger would create publicly-traded immuno-oncology biotechnology company developing novel products for treating early- and late-stage cancer- -Growing product pipeline utilizing Versamune ® , a novel, versatile, multi [...]
Tasly and Mesoblast Initiate Development and Regulatory Activities for MPC-150-IM Heart Failure Cell Therapy in China
26/11/2018
NEW YORK and MELBOURNE, Australia, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Tasly Pharmaceutical Group and Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that the first Joint Steering Committee (JSC) meeting for [...]
Innovate Biopharmaceuticals Strengthens Clinical Development with the Addition of Patrick H. Griffin, M.D., F.A.C.P.
26/11/2018
RALEIGH, N.C., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc . (Nasdaq: INNT), a clinical-stage biotechnology company focused on developing novel medicines for autoimmune and inflammatory diseases, [...]
Transactions under Novozymes’ stock buyback program
26/11/2018
Please read the full announcement in the attached PDF Attachment 2018_65_Stock_Buybackprogram_EN
Registration of the reduced quantity of shares in Nexstim Plc (the first phase)
26/11/2018
Company announcement, Helsinki, 26 November 2018 at 10:00 Registration of the reduced quantity of shares in Nexstim Plc (the first phase) The Extraordinary General Meeting of Nexstim Plc (NXTMH:HEX, NXTMS:STO), the [...]
Latvijas Juras medicinas centrs JSC: interim report for the 9 months of 2018
26/11/2018
Latvijas Juras medicinas centrs JSC: interim report for the 9 months of 2018, approved by the Board at 21.11.2018. Member of the Board: Juris Imaks, phone: 29512492
JSC Olainfarm Invites To Join Company’s Presentation At CEO Meets Investors Event In Riga
26/11/2018
JSC Olainfarm is inviting investors to join Olainfarm’s online presentation today at 11:45 (EET) at the annual CEO Meets Investor event in Riga. The presentation will be led by the Advisor to the Board of JSC Olainfarm [...]
Chi-Med Announces First Commercial Launch of Fruquintinib Capsules (Elunate®)
26/11/2018
LONDON, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces the first commercial launch of fruquintinib capsules (Elunate ® ) with the initiation of product [...]
Telix Pharmaceuticals Acquires Advanced Nuclear Medicine Ingredients (ANMI) SA
26/11/2018
MELBOURNE, Australia, BRUSSELS and LIÈGE, Belgium, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the [...]
MDxHealth (R): MDxHealth Announces Approval for SelectMDx for Prostate Cancer by New York State
26/11/2018
NEWS RELEASE REGULATED INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - 07.00 CET, 26 November 2018 - MDxHealth SA (Euronext: MDXH.BR) today announces that the New York State Department of Health has approved its [...]
MDxHealth (R) : MDxHealth annonce avoir reçu l'homologation de l'État de New York pour son test SelectMDx for Prostate Cancer
26/11/2018
COMMUNIQUÉ DE PRESSE INFORMATIONS RÉGLEMENTÉES IRVINE, CA, et HERSTAL, BELGIQUE - 07:00 CET, 26 novembre 2018 - MDxHealth SA (Euronext : MDXH.BR) annonce aujourd'hui avoir reçu l'homologation du département de la santé [...]
TLC to Attend Goldman Sachs Asia Pacific Healthcare Forum 2018
25/11/2018
TAIPEI, Taiwan and SOUTH SAN FRANCISCO, Calif., Nov. 25, 2018 (GLOBE NEWSWIRE) -- Taiwan Liposome Company, Ltd. (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company dedicated to the development [...]
Align Announces New iTero Updates and Connectivity to Improve Customer Experience and Workflow for Dental Practices
24/11/2018
New iTero software upgrade with enhanced functionality improves scan quality and patient privacy New iTero connectivity with exocad® and Dentrix® enhances both doctor and patient experience SAN JOSE, Calif., Nov. 23, [...]
ESPERITE (ESP): financial results for 2017 are published.
23/11/2018
Amsterdam, The Netherlands - 23 November 2018 ESPERITE N.V. (Euronext: ESP, "Esperite", "the Company" or "the Group") has published today its Annual Report for the year ended 31 December 2017. The 2017 Annual Report is [...]
Galapagos increases share capital through warrant exercises
23/11/2018
Mechelen, Belgium; 23 November 2018, 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from warrant exercises. Galapagos issued 30,800 new ordinary [...]
Quantity of shares in Nexstim Plc after completion of the first phase in reducing the quantity of shares
23/11/2018
Company announcement, Helsinki, 23 November 2018 at 21:00 Quantity of shares in Nexstim Plc after completion of the first phase in reducing the quantity of shares The Extraordinary General Meeting of Nexstim Plc (NXTMH: [...]

Pages